Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Russia
Biotech
Checkpoint ends combo drug trial, citing war in Ukraine
Checkpoint is calling it quits on a phase 3 combo trial of its cancer med because of enrollment problems stemming from the war in Ukraine.
Max Bayer
Aug 12, 2022 12:16pm
Intrivo CEO calls medtech startups to action to help Ukraine
Jun 17, 2022 9:35am
Siemens Healthineers to stay in Russia, as Siemens AG departs
May 12, 2022 2:55pm
EU warns clinical trial changes in Ukraine 'unavoidable'
Mar 30, 2022 2:27pm
Aeterna reports trial delays due to Russia's war in Ukraine
Mar 21, 2022 11:33am
As Russia prepared for war, Karuna's team prepped patients
Mar 3, 2022 11:00am